191 related articles for article (PubMed ID: 8980760)
1. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ
Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760
[TBL] [Abstract][Full Text] [Related]
2. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Cambau E; Bordon F; Collatz E; Gutmann L
Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
5. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
Herrera G; Aleixandra V; Urios A; Blanco M
FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
[TBL] [Abstract][Full Text] [Related]
6. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
Aleixandre V; Urios A; Herrera G; Blanco M
Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
Masecar BL; Robillard NJ
Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
[TBL] [Abstract][Full Text] [Related]
8. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.
Mouneimné H; Robert J; Jarlier V; Cambau E
Antimicrob Agents Chemother; 1999 Jan; 43(1):62-6. PubMed ID: 9869566
[TBL] [Abstract][Full Text] [Related]
9. Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
Heisig P; Tschorny R
Antimicrob Agents Chemother; 1994 Jun; 38(6):1284-91. PubMed ID: 8092826
[TBL] [Abstract][Full Text] [Related]
10. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.
Gensberg K; Jin YF; Piddock LJ
FEMS Microbiol Lett; 1995 Oct; 132(1-2):57-60. PubMed ID: 7590165
[TBL] [Abstract][Full Text] [Related]
11. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
[TBL] [Abstract][Full Text] [Related]
12. In vitro plasmid-encoded resistance to quinolones.
Gómez-Gómez JM; Blázquez J; Espinosa De Los Monteros LE; Baquero MR; Baquero F; Martínez JL
FEMS Microbiol Lett; 1997 Sep; 154(2):271-6. PubMed ID: 9311124
[TBL] [Abstract][Full Text] [Related]
13. Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium.
Kongsoi S; Changkwanyeun R; Yokoyama K; Nakajima C; Changkaew K; Suthienkul O; Suzuki Y
Drug Test Anal; 2016 Oct; 8(10):1065-1070. PubMed ID: 26514939
[TBL] [Abstract][Full Text] [Related]
14. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.
Cesaro A; Bettoni RR; Lascols C; Mérens A; Soussy CJ; Cambau E
J Antimicrob Chemother; 2008 May; 61(5):1007-15. PubMed ID: 18325893
[TBL] [Abstract][Full Text] [Related]
15. Characterization of high-level quinolone resistance in Campylobacter jejuni.
Gootz TD; Martin BA
Antimicrob Agents Chemother; 1991 May; 35(5):840-5. PubMed ID: 1649570
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gyrA mutations associated with fluoroquinolone resistance in Campylobacter coli by DNA sequence analysis and MAMA PCR.
Zirnstein G; Helsel L; Li Y; Swaminathan B; Besser J
FEMS Microbiol Lett; 2000 Sep; 190(1):1-7. PubMed ID: 10981681
[TBL] [Abstract][Full Text] [Related]
17. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
Bagel S; Hüllen V; Wiedemann B; Heisig P
Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.
Cullen ME; Wyke AW; Kuroda R; Fisher LM
Antimicrob Agents Chemother; 1989 Jun; 33(6):886-94. PubMed ID: 2548439
[TBL] [Abstract][Full Text] [Related]
20. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
Yoshida H; Bogaki M; Nakamura M; Nakamura S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1271-2. PubMed ID: 2168148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
